AkzoNobel and U.S.-based Axalta Coating Systems have offered remedies to the European Commission as they seek approval for their planned $25 billion merger. The concessions automatically extended the Commission’s preliminary review deadline by 10 working days, giving regulators more time to assess whether the transaction would harm competition in the global coatings market.
The deal would create a major coatings group
AkzoNobel is one of the world’s largest paint and coatings companies, with consumer and industrial operations in more than 150 countries. Axalta focuses almost entirely on high-performance coatings and has a particularly strong presence in the United States.
A combination would create a much larger global competitor across automotive refinishing, industrial coatings and other specialty markets.
EU regulators are focused on competition
The European Commission received formal notification of the transaction in September. Under EU merger rules, companies can propose remedies if regulators believe a deal may reduce competition in specific markets.
Those remedies can include selling businesses, licensing technology or changing commercial arrangements.
Vehicle refinishing may be the key issue
Reuters reported that AkzoNobel could offer to divest its vehicle-refinish business to address EU concerns. Neither the Commission nor the companies publicly detailed the final package of concessions submitted this week.
Automotive refinishing is a concentrated market in which scale, distribution and brand relationships with repair shops can create significant barriers to entry.
The review deadline moves into November
Submitting remedies during the initial review phase extends the timetable so regulators can test the proposed concessions with competitors and customers.
The Commission can then approve the merger, demand stronger remedies or open a deeper Phase II investigation.
Competitors are watching closely
The combined company would compete with large global players including BASF, Nippon Paint, Sherwin-Williams and Kansai Nerolac.
Rivals may argue that the merger would increase concentration in certain product categories, while the companies are likely to emphasize global competition and potential efficiency gains.
Scale matters in coatings
Coatings companies benefit from global manufacturing, research and distribution networks. Large customers such as automakers and industrial manufacturers often want suppliers that can serve multiple regions consistently.
A larger group can spread research costs across more products and negotiate better procurement terms, but those same scale advantages can also make it harder for smaller competitors to keep pace.
Industrial demand is changing
Coatings are increasingly engineered for specific technical requirements, including electric vehicles, corrosion resistance, lightweight materials and lower-emission manufacturing.
That has increased the importance of research spending and specialized product development.
Investors will focus on execution risk
Even if regulators approve the merger, integration would be complex. The two companies operate across many countries, factories and customer segments.
Combining sales teams, manufacturing networks and information systems without losing customers will be a major challenge.
Divestitures can reduce the strategic benefit
Remedies may help win approval but can also reduce the value of a deal if companies are forced to sell profitable operations.
The final economic impact will therefore depend not only on whether the merger is approved but on what assets must be surrendered.
The transaction is part of a broader consolidation trend
Industrial companies are pursuing larger cross-border deals as they seek scale in slower-growth markets and invest in higher-value technologies.
Regulators, however, are applying closer scrutiny to transactions that could weaken competition or increase pricing power.
Next step: market testing
The Commission is expected to seek feedback from customers and competitors before making a decision. That process will determine whether the current remedy package is sufficient.
For AkzoNobel and Axalta, the coming weeks will show whether a targeted divestiture can preserve the strategic logic of the $25 billion combination while satisfying Europe’s competition authorities.
Sources
- European Commission merger notification, Case M.12269
- Reuters, Oct. 16, 2026
